In two months of 2018, Ontario’s 14 million people spend an average of $1.54/person on Cannabis – dwarfed by the $13.81/person spent by residents of P.E.I. Total Ontario cannabis sales are projected to be about $129 million for 2019.
TGOD is the largest licensed producer of 100% certified organic cannabis in Canada. All TGOD cannabis is certified by ECOCERT, a global organic certification body.
A pot grower to signing up to ECOCERT, is like a UFC fighter signing up the Voluntary Anti-Doping Association (VADA). VADA’s fighters are subjected to unannounced testing at any time during the eight weeks prior to a scheduled fight.
ECOCERT verifies that production standards are met through surprise audits, and product analysis.
Organic cannabis is grown in living soil without the use of synthetic fertilizers, pesticides or herbicides. The result is a cleaner, premium product for Canadian consumers across both medical and recreational uses
Focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market – TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
Aurora Cannabis (ACB.T) has invested approximately $78 million in TGOD for a 20% off-take agreement on Canadian production.
Right now, for LPs wanting access to the Ontario market, Ontario Cannabis Retail Corporation is the only game in town. In the video below, they comprehensively answer the question, “Why should I trust OSC as my cannabis retailer?”
In April 2019, the Ontario retail weed landscape will change. The government will supply cannabis products to “licensed private retail stores across the province.”
More than half of Ontario’s eligible municipalities have opted in to host cannabis stores.
The first 25 retailers eligible to apply for cannabis licenses were announced last month.
On February 8, 2019 one Ontario retailer was disqualified for, “breaking a rule that prohibits someone from changing the name of the person on an application or the corporate structure of the company operating the store.”
The Ontario government’s approach to cannabis market is a perfectly executed educational/sales hybrid.
“Because everyone’s physiology and Endocannabinoid System is different,” states the website, “the effects of cannabis are highly individualized.”
A product’s THC potency is expressed as a percentage. 20% THC content is considered to be “very strong,” and 33% is the highest potency level currently available.
Cannabidiol, or CBD, is another of the cannabis plant’s active cannabinoids. Consumed on its own, CBD generally has no intoxicating effect.
When present in a product with at least a 1:1 ratio of THC to CBD, CBD may negate some of the psychoactive effects of THC.
If you prefer a minimally psychoactive experience, choose CBD-only products or those with a high ratio of CBD to THC.
Like with most plants, there are male and female cannabis plants. Both produce pre-flowers, but only female and hermaphroditic plants fully blossom.
The flowering tip of the female plant, often called the bud, is the part harvested for consumption because it contains the highest concentration of cannabinoids, the chemical compound that produces the effects of cannabis.
TGOD’s Valleyfield site revised plan anticipates by Q4, 2019 289,000 square feet; 65,000 kilograms capacity, and a Central Processing facility for all phases: 443,000 square feet. By 2020 – all facilities: 1,310,000 square feet, capable of producing 185,000 kilograms
- Deployed $33 million on construction facilities in Hamilton, Ontario and Valleyfield, Quebec
- Commercial production in both facilities anticipated in 2019.
- Developing five new strains for medical and recreational markets
- Signed a deal with european giant Knud Jepsen to establish JVs ventures for commercial production of cannabis and cannabis oils and to develop and patent elite cannabis genetics.
- Secured approvals from the City’s Agricultural and Rural Affairs Committee, the Planning Committee, the Ontario Federation of Agriculture.
- Hamilton’s 2 existing facilities (total 27,000sq ft), already zoned to produce medical cannabis.
- Sale of premium, certified-organic cannabis to medical patients through integration with HelloMD’s online clinic services.
- Invested in Jamaica, through Epican Medicinals. Planned expansion into four more retail stores, with production capacity to 14,000 kgs.
- Gained right to use EnWave’s REV dehydration technology to dry organic cannabis in its Canadian operations
- HemPoland booked sales of CBD oil and other industrial hemp products across Europe
- Advancement of operations in Greece.
- Anticipates 170,000 kgs of annual cannabis capacity across Canada and Jamaica.
- JV’d with one of largest pharmaceutical distributors in Mexico.
- Radically expanded operations, administration and marketing infrastructure.
“Ontario is a critical component to TGOD’s national recreational rollout,” stated Brian Athaide, Director and CEO. “This represents the first of many provincial supply agreements planned for our premium organic product as our domestic facilities near completion and production increases throughout 2019.”
Full Disclosure: TGOD is an Equity Guru marketing client, and we own the stock.Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.